CI vs. MDLN: Cigna vs. Medline Stock Comparison

Company Profile

Cigna (CI) and Medline (MDLN) both fall under the Health Care Equipment & Services industry group, but CI is classified in Health Care Providers & Services while MDLN is classified in Health Care Equipment & Supplies.

Cigna (CI) has been public since March 31, 1982, giving it decades of market history across multiple cycles, while Medline (MDLN) listed only on December 17, 2025 and lacks comparable through-cycle data.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Medline (MDLN) reports a negative beta of -0.93, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. Cigna (CI) has a non-negative beta of 0.24.

Risk-Adjusted Performance

Risk-Return Positioning

Both CI and MDLN need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Profitability

Cigna (CI) at 15.65% sits in the top ROE quartile, while Medline (MDLN) at 4.85% is closer to the peer norm — stronger capital efficiency for CI.

Both Cigna (CI) at 2.09% and Medline (MDLN) at 1.85% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Both Cigna (CI) at 3.48% and Medline (MDLN) at 5.22% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

Only one side can be read here: Cigna (CI) reports revenue growth of 11.26%, ranked against its industry; Medline (MDLN) has no revenue growth figure this period.

Both companies show strong earnings momentum, but Medline (MDLN) at 117.38% is the standout with EPS growth above its industry range; Cigna (CI) at 83.00% also sits in the top quartile.

Growth Metrics

Financial Strength

Medline (MDLN) at 4.04 carries current ratio above its industry’s typical mid-range, while Cigna (CI) at 0.84 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.

Both Cigna (CI) at 0.71 and Medline (MDLN) at 0.65 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Medline (MDLN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cigna (CI) reports a yield of 2.05%, ranking against industry peers normally.

Medline (MDLN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cigna (CI) reports a payout of 27.29%, ranking against industry peers normally.

Dividend Metrics

Valuation

Cigna (CI) at 12.94 sits in the cheaper P/E ratio quartile, while Medline (MDLN) at 90.09 trades above its peer range — a wide earnings-valuation gap relative to industry peers.

Cigna (CI) at 0.27 sits in the cheaper P/S ratio quartile while Medline (MDLN) at 1.70 prices around its industry’s middle — CI costs less per dollar of sales, though read it alongside growth and margins.

On P/B ratio, both Cigna (CI) at 1.79 and Medline (MDLN) at 2.95 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics